A label‐free and signal‐amplifiable fluorescent biosensor based on aptamer‐conjugated gold nanoparticles and hybridization chain reaction for determination of carcinoembryonic antigen
Authors:
- 16 September 2024
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 39 (9) , e4899
Abstract
The sensitive detection of cancer biomarkers is crucial for early accurate diagnostics and therapy of cancer patients. Carcinoembryonic antigen (CEA) is a tumor‐associated antigen derived from colon cancer and embryonic tissues. In this study, we have developed a label‐free fluorescence biosensing platform for the quantification of CEA with the “turn‐on” signal output. This platform employs a label‐free strategy that incorporates an aptamer‐modified gold nanoparticle (Apt@AuNP) probe for the recognition of CEA, in combination with hybridization chain reaction (HCR) amplification. In the presence of target CEA, Apt@AuNPs selectively capture CEA, resulting in a reduction of subsequent complementary chains (CP) binding on Apt@AuNPs. The remaining CP, acting as the initiator sequence for HCR, triggers the HCR, leading to the formation of abundant G‐quadruplex structures. By employing Thioflavin T (ThT) for the formation of G‐quadruplex/ThT complexes, the biosensor exhibits a significant enhancement of the fluorescence signal. Under optimized conditions, the biosensor platform demonstrates a limit of detection of 0.03 nM and a linear range from 0.1 to 2.5 nM. Additionally, the specificity investigation reveals the high selectivity of this fluorescent biosensor. Finally, the performance of this method has been validated by successfully detecting CEA in real‐life samples, highlighting its potential for clinical applications.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20200907, BK20200908)
- Jiangsu University
This publication has 35 references indexed in Scilit:
- Preparation, applications, and challenges of functional DNA nanomaterialsNano Research, 2022
- Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020Cancer Communications, 2021
- A label-free and double recognition–amplification novel strategy for sensitive and accurate carcinoembryonic antigen assayBiosensors and Bioelectronics, 2019
- Bio-bar-code-based photoelectrochemical immunoassay for sensitive detection of prostate-specific antigen using rolling circle amplification and enzymatic biocatalytic precipitationBiosensors and Bioelectronics, 2018
- A cascade amplification strategy of catalytic hairpin assembly and hybridization chain reaction for the sensitive fluorescent assay of the model protein carcinoembryonic antigenMicrochimica Acta, 2018
- Papain-functionalized gold nanoparticles as heterogeneous biocatalyst for bioanalysis and biopharmaceuticals analysisAnalytica Chimica Acta, 2017
- Glycans and glycoproteins as specific biomarkers for cancerAnalytical and Bioanalytical Chemistry, 2016
- Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateInternational Journal of Cancer, 2013
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasisCancer and Metastasis Reviews, 2013
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer AssociationGastric Cancer, 2013